Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY: MCK )

555.94 +1.33 (+0.24%)
Streaming Delayed Price Updated: 10:11 AM EDT, May 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about McKesson Corp

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
These Analysts Increase Their Forecasts On McKesson Following Q4 Results
Via Benzinga
Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
MCK Stock Earnings: McKesson Misses EPS, Misses Revenue for Q4 2024
MCK stock results show that McKesson missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2024. 
Via InvestorPlace
McKesson (MCK) Q4 2024 Earnings Call Transcript
MCK earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About McKesson?
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
Via Benzinga
How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings Report
McKesson offers a quarterly dividend amount of 62 cents per share. How can investors pocket a regular $500 monthly? 
Via Benzinga
Investor Optimism Decreases Slightly, But Dow Records Gains For 4th Day
Via Benzinga
Topics Stocks
Exposures US Equities
Disney, Electronic Arts And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Forget Individual Consumer Stocks: Buy This ETF Instead
Here's an ETF that outperforms the S&P 500 over a longer time horizon. 
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
McKinsey Faces Criminal Probe By DOJ For Opioid Consulting: Report
The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its role in advising major opioid manufacturers on increasing sales. The... 
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
Via Benzinga
Peering Into McKesson's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Via Benzinga
The Top 3 Healthcare Stocks to Buy in April 2024
These are strong buy stocks within the healthcare industry that investors should watch in 2024 due to their strong returns. 
Via InvestorPlace
Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson
The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest. 
Via Benzinga
Top Stock Reports For Apple, Nvidia & Eli Lilly
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., NVIDIA Corporation, and Eli Lilly and Company. 
Via Talk Markets
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters reports. Attorney Aparna Yenamandra highlights broad stakeholder agreement,... 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Which Stocks Will Dominate The Future Of Tech? UBS Shares Its Top Picks In AI, Healthtech, Greentech, And Fintech
In a recent report, global wealth manager UBS has identified the sectors that are likely to drive the next wave of technological innovation and the stocks that stand to benefit. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
How Is The Market Feeling About McKesson?
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
Via Benzinga
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices. 
Via Benzinga
3 Attractive Medical Stocks To Buy After Earnings
Quite a few top-rated stocks have highlighted this week’s earnings lineup with now appearing to be an ideal time to buy. Following their favorable quarterly results, here are 3 intriguing healthcare... 
Via Talk Markets
Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More'
McKesson beats expectations with Q3 2024 sales of $80.9 billion, up 15%. U.S. Pharmaceutical Segment thrives, adjusted EPS at $7.74, exceeding consensus. 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today
Via Benzinga
McKesson (MCK) Q3 2024 Earnings Call Transcript
MCK earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
McKesson Corporation (NYSE: MCK) is expected to release earnings results for its third quarter, after the closing bell on Feb. 7, 2024. 
Via Benzinga
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.